Q3 2016 13F Holders as of 9/30/2016
-
Type / Class
-
Equity / COM
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
26.5M
-
Shares change
-
-738K
-
Total reported value, excl. options
-
$87.4M
-
Value change
-
-$2.11M
-
Put/Call ratio
-
0
-
Number of buys
-
32
-
Number of sells
-
-34
-
Price
-
$3.30
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q3 2016
95 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q3 2016.
REGULUS THERAPEUTICS INC - COM (RGLS) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.5M shares
.
Largest 10 shareholders include FMR LLC (7.92M shares), WELLINGTON MANAGEMENT GROUP LLP (4.65M shares), BlackRock Fund Advisors (1.77M shares), VANGUARD GROUP INC (1.34M shares), AXA (1.05M shares), South Dakota Investment Council (900K shares), BlackRock Institutional Trust Company, N.A. (770K shares), RENAISSANCE TECHNOLOGIES LLC (645K shares), WELLS FARGO & COMPANY/MN (630K shares), and STATE STREET CORP (562K shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.